Diethylcarbamazine Citrate

枸缘酸乙胺嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDiethylcarbamazine Citrate
Drug Alias Name乙胺嗪枸橼酸盐dietilcarbamazina乙胺嗪柠檬酸盐diethylcarbamazinumNotezine +[9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-1 inhibitors
TargetsCyclooxygenase-1
Therapy Area/IndicationsElephantiasis, FilarialFilariasis
Global Approved IndicationsElephantiasis, FilarialFilariasis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1950/11/13
Country/TerritoryCanadaUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMitsubishi Tanabe Pharma
Active IndicationsFilariasis
Inactive IndicationsElephantiasis, Filarial

Other Information

ATC CodeP02CB02